Modulate Bio Inc.

CIK 2026915 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Modulate Bio Inc..

Recent SEC filings

FiledFormAccession number
Apr 7, 2026D/A0002026915-26-000001
Jun 12, 2025D/A0002026915-25-000001
Jun 13, 2024D0002026915-24-000001